OLIGOCREATOR

Owner

Goods & Services

Consultancy services relating to health care and pharmaceutical product development in the fields of biochemistry, nucleic acids, bioinformatics; consultancy services to third parties in the field of the evaluation of safety and efficacy of pharmaceuticals, namely pharmaceutical consultancy services concerning the safety and efficacy of pharmaceuticals in connection with treatment of patients

Scientific research services in the fields of biochemistry, nucleic acids, and bioinformatics, in particular molecular biology techniques, especially antisense techniques, all excluding the field of cell culture product; design of pharmaceutical active ingredients by the use of bioinformatics techniques; development of pharmaceutical products by the use of bioinformatics techniques being testing and diagnostic procedures; bioinformatic services for scientific research purposes in the pharmaceutical and biotechnological industry, namely, computational design and optimization of oligonucleotide sequences, sequence analysis of nucleic acids, target identification and validation of oligonucleotide targets and nucleic acid sequences using bioinformatic methods, in silico screening and prediction of efficacy, safety and off-target effects of nucleic acid therapeutics, analysis of gene expression and multiomics data for the investigation of off-target downregulation and target-downregulation induced biological downstream effects, integration and analysis of biological data sets, selection of candidate oligonucleotides based on computational and experimental data, application of artificial intelligence and machine learning for drug discovery and sequence optimization; scientific research services to characterize pharmaceutical active ingredients, especially oligonucleotides in cell culture assays in vitro as well as in vivo for the assessment of efficacy, specificity, safety and therapeutic effects; evaluation of pharmaceutical products with respect to their safety and efficacy to assure compliance with industry standards

Licensing of industrial property rights arising from scientific research services in the fields of biochemistry, nucleic acids, and bioinformatics, in particular molecular biology techniques, especially antisense techniques, all excluding the field of cell culture product; licensing of industrial property rights arising from the design of pharmaceutical active ingredients using molecular biology techniques, especially antisense techniques; licensing of industrial property rights arising from the development of pharmaceutical products using molecular biology techniques being testing and diagnostic procedures; licensing of industrial property rights arising from information technology services in the nature of bioinformatic data analysis for the pharmaceutical and biotechnological industry; licensing of industrial property rights arising from services for evaluating the efficacy and safety of pharmaceutical products